MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1872-034x.2011.00793.x

Медицинская библиотека · Hepatology research : the official journal of the Japan Society of Hepatology · 2011

Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis.

Hiura Masaaki, Abe Shintaro, Tabaru Akinari, Shimajiri Shohei, Hanami Kentaro, Saito Kazuyoshi, Tanaka Yoshiya, Harada Masaru

СтатьяПеревод в очереди

Аннотация

A 71-year-old male patient was diagnosed with rheumatoid arthritis (RA) in 2000. Various disease-modifying anti-rheumatic drugs (DMARDs) and an anti-tumor necrosis factor biologic etanercept were administrated, but were unable to control the disease activity of RA. He was then diagnosed with rheumatoid vasculitis and received a total of 3 courses of an anti-interleukin-6 receptor antibody, tocilizumab. After the 3 courses of tocilizumab therapy, ascites and renal dysfunction gradually appeared and he was admitted to our hospital. Biochemical data suggested that he had developed decompensated liver cirrhosis. His renal function deteriorated rapidly, and he died 9 days after the admission. Serum aminotransferase levels had been relatively low during the treatment with tocilizumab, however, autopsy showed marked atrophy of the liver. Immunohistochemical analysis revealed that the hepatocytes had fallen into apoptosis and that hepatic regeneration had been extremely suppressed. Although molecular target drugs such as tocilizumab are being widely used and are important emerging treatment options in adult patients with moderate to severe RA, these drugs could induce liver failure by inhibiting liver regeneration as in this case. Physicians need to stay alert to the impact of these drugs on liver regeneration and should follow up with ultrasonography or computed tomography.

Для цитирования: Hiura Masaaki, Abe Shintaro, Tabaru Akinari, Shimajiri Shohei, Hanami Kentaro, Saito Kazuyoshi, Tanaka Yoshiya, Harada Masaru. Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis.. Hepatology research : the official journal of the Japan Society of Hepatology. 2011. DOI: 10.1111/j.1872-034x.2011.00793.x.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.